Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expectancy and Stimulants for Cognitive Enhancement
NCT04635826Phase 4Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2025
- Primary completion
- Jul 2029
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dextroamphetamine + amphetamine, sponsored by University of Alabama at Birmingham. Planned start Jul 2025; status: withdrawn.
02
Drugs
dextroamphetamine + amphetamine
Beyond the preview
Go deeper on NCT04635826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04635826.